Properties
Description
Cobimetinib hemifumarate prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
Molecular Formula
C25H25F3IN3O6
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Cobimetinib hemifumarate can be used to study the inhibition of MEK1/2 in oncological research.